Heterocyclic amide compounds as cell adhesion inhibitors

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 5/078 (2006.01) A61K 31/401 (2006.01) A61K 31/472 (2006.01) A61K 38/05 (2006.01) C07D 207/48 (2006.01) C07D 211/96 (2006.01) C07D 217/26 (2006.01) C07K 5/06 (2006.01)

Patent

CA 2291778

Compounds of formula (I) are antagonists of VLA-4 and/or .alpha.4.beta.7, and as such are useful in the inhibition or prevention of cell adhesion and cell- adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.

Des composés de formule (I) sont des antagonistes de VLA-4 et/ou de .alpha.¿4?.beta.¿7? et sont, en tant que tels, utiles pour inhiber ou empêcher l'adhésion cellulaire et pour lutter contre des pathologies induites par l'adhésion cellulaire. Ces composés peuvent être formulés sous forme de compositions pharmaceutiques et sont adaptés pour être utilisés dans le traitement de l'asthme, des allergies, des inflammations, de la sclérose en plaques et d'autres maladies inflammatoires et auto-immunes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Heterocyclic amide compounds as cell adhesion inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic amide compounds as cell adhesion inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic amide compounds as cell adhesion inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1383157

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.